Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.

• Laaksonen R Zora Biosciences, Espoo, Finland Medical School, Tampere University, Tampere, Finland Finnish Clinical Biobank Tampere, University Hospital of Tampere, Tampere, Finland reijo.laaksonen@zora.fi.
• Ekroos K Zora Biosciences, Espoo, Finland.
• Sysi-Aho M Zora Biosciences, Espoo, Finland.
• Hilvo M Zora Biosciences, Espoo, Finland.
• Vihervaara T Zora Biosciences, Espoo, Finland.
• Kauhanen D Zora Biosciences, Espoo, Finland.
• Suoniemi M Zora Biosciences, Espoo, Finland.
• Hurme R Zora Biosciences, Espoo, Finland.
• März W Medical Clinic V (Nephrology, Hypertensiology, Rheumatology, Endocrinology, Diabetology), Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany synlab Academy, synlab Holding Deutschland GmbH, Mannheim and Augsburg, Germany.
• Scharnagl H Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria.
• Stojakovic T Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University Graz, Graz, Austria.
• Vlachopoulou E Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland.
• Lokki ML Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland.
• Nieminen MS Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.
• Klingenberg R Department of Cardiology, University Heart Center, University Hospital Zürich and University of Zürich, Zürich, Switzerland.
• Matter CM Department of Cardiology, University Heart Center, University Hospital Zürich and University of Zürich, Zürich, Switzerland.
• Hornemann T Institute of Clinical Chemistry, University Hospital, Zürich, Switzerland.
• Jüni P Applied Health Research Centre (AHRC), Li Ka Shing Knowledge Institute of St. Michael's Hospital, and Department of Medicine, University of Toronto, Toronto, Canada.
• Rodondi N Department of General Internal Medicine, University Hospital Bern, Bern, Switzerland Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland.
• Räber L Cardiovascular Center, Department of Cardiology, University Hospital Bern, Bern, Switzerland.
• Windecker S Cardiovascular Center, Department of Cardiology, University Hospital Bern, Bern, Switzerland.
• Gencer B Cardiovascular Center, Department of Cardiology, University Hospital Geneva, Geneva, Switzerland.
• Pedersen ER Department of Clinical Science, University of Bergen, Bergen, Norway.
• Tell GS Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
• Nygård O Department of Clinical Science, University of Bergen, Bergen, Norway Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.
• Mach F Cardiovascular Center, Department of Cardiology, University Hospital Geneva, Geneva, Switzerland.
• Sinisalo J Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland Heart and Lung Center, Helsinki University Hospital, Helsinki, Finland.
• Lüscher TF Institute of Clinical Chemistry, University Hospital, Zürich, Switzerland.

Show more…

Acute coronary syndrome

Biomarker

Ceramide

Coronary artery disease

LDL-cholesterol

Prognosis

Risk prediction

Acute Coronary Syndrome

Biomarkers

Ceramides

Cholesterol, LDL

Coronary Artery Disease

Humans

Prognosis

Prospective Studies

Risk Factors